Option exercise, 10b5-1 sale reported by SYRE (NASDAQ: SYRE)

Rhea-AI Filing Summary

SYRE reports transactions in Common Stock under Rule 144. The excerpt lists an exercise of stock options resulting in 78,333 shares on 05/01/2026, and prior 10b5-1 sales of 7,958 shares on 04/01/2026 for $397,900. Broker: Morgan Stanley Smith Barney LLC.

Insights

Securities Compliance Counsel

Rule 144 notice of stock disposition and an option exercise are disclosed.

The filing lists an exercise of stock options for 78,333 shares dated 05/01/2026 and prior 10b5-1 sales of 7,958 shares on 04/01/2026 for $397,900. These entries align with routine compliance reporting under resale rules and scheduled trading plans.

Timing and cash‑flow treatment are stated in the excerpt: the exercise was settled for cash and broker details are provided. Subsequent filings may show transfer destinations or confirm Rule 144 resale eligibility.

Equity Transactions Analyst

Transaction scale is modest relative to typical company floats; details are administrative.

The record shows a single large option exercise and earlier 10b5-1 sales; the 10b5-1 sale realized $397,900 on 04/01/2026. The excerpt names the executing broker, which is standard for execution traceability.

Investor impact is limited from this excerpt alone; additional filings would be needed to assess any dilution or holdings change.

Key Figures

Option exercise shares: 78,333 shares 10b5-1 sale shares: 7,958 shares Proceeds from 10b5-1 sale: $397,900

3 metrics

Option exercise shares 78,333 shares exercise of stock options on 05/01/2026

10b5-1 sale shares 7,958 shares 10b5-1 sale on 04/01/2026

Proceeds from 10b5-1 sale $397,900 cash received on 04/01/2026

Key Terms

10b5-1, exercise of stock options, Rule 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for SHELDON SLOAN 221 Crescent Street"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

exercise of stock options financial

"Exercise of Stock Options | Issuer | 78333 | 05/01/2026"

Rule 144 regulatory

"Filer Information | 144: Filer Information"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	78333	5831891.85	78540164	05/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2026	Exercise of Stock Options	Issuer			78333	05/01/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SHELDON SLOAN 221 Crescent Street Building 23 Suite 105 Waltham MA 02453	Common	04/01/2026	7958	397900.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does SYRE's Form 144 disclose about recent transactions?

It discloses an exercise of stock options for 78,333 shares dated 05/01/2026 and prior 10b5-1 sales of 7,958 shares on 04/01/2026 that totaled $397,900.

Who acted as broker for the reported SYRE transactions?

The broker listed is Morgan Stanley Smith Barney LLC with an address at 1 New York Plaza. The excerpt ties the broker to the reported Common stock transactions.

Was the option exercise for SYRE settled in cash?

Yes. The excerpt indicates the exercise of stock options on 05/01/2026 was settled for cash, per the transaction line in the provided content.

What were the proceeds from the 10b5-1 sales mentioned?

The 10b5-1 sale on 04/01/2026 involved 7,958 shares and returned $397,900 according to the excerpt's transaction record.